Back to Search Start Over

Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11β-hydroxysteroid dehydrogenase type 1-deficient mice

Authors :
Morton, Nicholas M.
Paterson, Janice M.
Masuzaki, Hiroaki
Holmes, Megan C.
Staels, Bart
Fievet, Catherine
Walker, Brian R.
Flier, Jeffrey S.
Mullins, John J.
Seckl, Jonathan R.
Source :
Diabetes. April 2004, Vol. 53 Issue 4, p931, 8 p.
Publication Year :
2004

Abstract

The metabolic syndrome (visceral obesity, insulin resistance, type 2 diabetes, and dyslipidemia) resembles Cushing's Syndrome, but without elevated circulating glucocorticoid levels. An emerging concept suggests that the aberrantly elevated levels of the intracellular glucocorticoid reamplifying enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1) found in adipose tissue of obese humans and rodents underlies the phenotypic similarities between idiopathic and 'Cushing-oid' obesity. Transgenic overexpression of 11β-HSD-1 in adipose tissue reproduces a metabolic syndrome in mice, whereas 11β-HSD-1 deficiency or inhibition has beneficial metabolic effects, at least on liver metabolism. Here we report novel protective effects of 11β-HSD-1 deficiency on adipose function, distribution, and gene expression in five in 11β-HSD-1 nullizygous (11β-HSD-[1.sup.-/-]) mice. 11β-HSD-[1.sup.-/-] mice expressed lower resistin and tumor necrosis factor-α, but higher peroxisome proliferator-activated receptor-γ, adiponectin, and uncoupling protein-2 mRNA levels in adipose, indicating insulin sensitization. Isolated 11β-HSD-[1.sup.-/-] adipocytes exhibited higher basal and insulin-stimulated glucose uptake, 11β-HSD-[1.sup.-/-] mice also exhibited reduced visceral fat accumulation upon high-fat feeding. High-fat-fed 11β-HSD-[1.sup.-/-] mice rederived onto the C57BL/6J strain resisted diabetes and weight gain despite consuming more calories. These data provide the first in vivo evidence that adipose 11β-HSD-1 deficiency beneficially alters adipose tissue distribution and function, complementing the reported effects of hepatic 11β-HSD-1 deficiency or inhibition.<br />Chronic exposure to high circulating glucocorticoid levels (Cushing's syndrome) causes visceral obesity and the associated metabolic abnormalities of insulin resistance, type 2 diabetes, dyslipidemia, and hypertension. Similar metabolic abnormalities occur [...]

Details

Language :
English
ISSN :
00121797
Volume :
53
Issue :
4
Database :
Gale General OneFile
Journal :
Diabetes
Publication Type :
Periodical
Accession number :
edsgcl.115408037